Dual COX-2/5-LOX inhibition suppresses prostaglandin/leukotriene production, downregulates NF-κB/MAPK pathways, and attenuates cartilage degradation in arthritis models (115). The gene discussed is NFKB1; the disease is arthritic joint disease.